Lesotho vs Rwanda: HIV/AIDS deaths averted by antiretroviral therapy
Lesotho
16,464 deaths
in 2024
Rwanda
13,299 deaths
in 2024
Lesotho rank
15th
Rwanda rank
18th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Lesotho
- Rwanda
How they compare
Lesotho currently reports 16,464 deaths against 13,299 deaths in Rwanda, a difference of 3,165 deaths.
That makes Lesotho's figure about 1.2 times Rwanda's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Rwanda ahead.
Lesotho ranks 15th and Rwanda ranks 18th of 157 countries.
Across the 4 decades both report, Lesotho averaged higher in 2 and Rwanda in 1.
Head to head by decade
| Decade | Lesotho | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 3,511 deaths | 3,990 deaths | 478.85 deaths | Rwanda |
| 2010s | 15,323 deaths | 12,999 deaths | 2,323 deaths | Lesotho |
| 2020s | 17,301 deaths | 13,654 deaths | 3,646 deaths | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Lesotho or Rwanda?
- Lesotho, at 16,464 deaths against 13,299 deaths in Rwanda as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Lesotho and Rwanda?
- 3,165 deaths, with Lesotho ahead.
- How many years of comparable data are there for Lesotho and Rwanda?
- 35 years are reported by both, from 1990 to 2024.
- How do Lesotho and Rwanda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Lesotho ranks 15th and Rwanda ranks 18th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.